Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
Open Access
- 24 November 2022
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 50 (6), 1643-1658
- https://doi.org/10.1042/bst20220415
Abstract
Natural infection with SARS-CoV-2 induces a robust circulating memory B cell (Bmem) population, which remains stable in number at least 8 months post-infection despite the contraction of antibody levels after 1 month. Multiple vaccines have been developed to combat the virus. These include two new formulations, mRNA and adenoviral vector vaccines, which have varying efficacy rates, potentially related to their distinct capacities to induce humoral immune responses. The mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) elicit significantly higher serum IgG and neutralizing antibody levels than the adenoviral vector ChAdOx1 (AstraZeneca) and Ad26.COV2.S (Janssen) vaccines. However, all vaccines induce Spike- and RBD-specific Bmem, which are vital in providing long-lasting protection in the form of rapid recall responses to subsequent infections. Past and current SARS-CoV-2 variants of concern (VoC) have shown the capacity to escape antibody neutralization to varying degrees. A booster dose with an mRNA vaccine following primary vaccination restores antibody levels and improves the capacity of these antibodies and Bmem to bind viral variants, including the current VoC Omicron. Future experimental research will be essential to evaluate the durability of protection against VoC provided by each vaccine and to identify immune markers of protection to enable prognostication of people who are at risk of severe complications from COVID-19.Keywords
This publication has 140 references indexed in Scilit:
- Clonal selection in the germinal centre by regulated proliferation and hypermutationNature, 2014
- Multiple routes to B-cell memoryInternational Immunology, 2012
- Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutantsThe Journal of Experimental Medicine, 2011
- Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathwaysBlood, 2011
- Complement-Dependent Transport of Antigen into B Cell FolliclesThe Journal of Immunology, 2010
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- B Cells Acquire Particulate Antigen in a Macrophage-Rich Area at the Boundary between the Follicle and the Subcapsular Sinus of the Lymph NodeImmunity, 2007
- B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin productionEuropean Journal of Immunology, 1997
- Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70European Journal of Immunology, 1996
- Lack of evidence for proofreading mechanisms associated with an RNA virus polymeraseGene, 1992